IRS1 and breast cancer: The importance of IRS signalling in cancer has been reported by Chang et al. 29, showing that IRS1 is constitutively phosphorylated in a variety of human tumours, including breast cancer, and that dominant negative IRS1 abolishes tumour cell growth in vitro.